Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation

► Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is involved in Tat-induced NADPH oxidase stimulation. ► NF-κB nuclear translocation in Tat-treated MAGI cells is dependent on Nox2 activation. ► Akt/NADPH oxidase pathway is involved in Tat-induced LTR transactivation in MAGI cells. Human...

Full description

Saved in:
Bibliographic Details
Published inArchives of biochemistry and biophysics Vol. 505; no. 2; pp. 266 - 272
Main Authors Zhang, Hong-Sheng, Sang, Wei-Wei, Ruan, Zheng, Wang, Yu-Ou
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.01.2011
Subjects
Online AccessGet full text
ISSN0003-9861
1096-0384
1096-0384
DOI10.1016/j.abb.2010.10.018

Cover

Abstract ► Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is involved in Tat-induced NADPH oxidase stimulation. ► NF-κB nuclear translocation in Tat-treated MAGI cells is dependent on Nox2 activation. ► Akt/NADPH oxidase pathway is involved in Tat-induced LTR transactivation in MAGI cells. Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation.
AbstractList Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation.
Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation.Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation.
► Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is involved in Tat-induced NADPH oxidase stimulation. ► NF-κB nuclear translocation in Tat-treated MAGI cells is dependent on Nox2 activation. ► Akt/NADPH oxidase pathway is involved in Tat-induced LTR transactivation in MAGI cells. Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation.
Author Zhang, Hong-Sheng
Wang, Yu-Ou
Sang, Wei-Wei
Ruan, Zheng
Author_xml – sequence: 1
  givenname: Hong-Sheng
  surname: Zhang
  fullname: Zhang, Hong-Sheng
  email: zhanghs@bjut.edu.cn
– sequence: 2
  givenname: Wei-Wei
  surname: Sang
  fullname: Sang, Wei-Wei
– sequence: 3
  givenname: Zheng
  surname: Ruan
  fullname: Ruan, Zheng
– sequence: 4
  givenname: Yu-Ou
  surname: Wang
  fullname: Wang, Yu-Ou
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21029719$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1uGyEUhVGVqHHSPkA3Fbumi7G5zAww6iqNmh_JSqXKyRYxwKS4M4wD2G1erQ_RZyqOk00X7ga46DvnSuccowM_eovQOyBTIMBmy6lq2yklT_OUgHiFJkAaVpBSVAdoQggpi0YwOELHMS4JAagYfY2OKBDacGgmaDj7kWY34y86u7ko_vz-jKO796p3_h6vVPr-Uz1iF7Hzm7HfWJMfeKFS4bxZ6zxeXd8VgPsx08mGwWUlDnZlVcKn88W3jzgF5aPSyW1UcqN_gw471Uf79vk-QbcXXxbnV8X86-X1-dm80BWIVGhTEmGIAQHAjaIMmgpq1YHoKOfKaqi6yuaDVV3X1qylZWOMgZY3LWU1KU_Qh53vKowPaxuTHFzUtu-Vt-M6SlHWAIzXNJOne0nglFQlz-v_jxJKRF2XbIu-f0bX7WCNXAU3qPAoX3LPAN8BOowxBttJ7dJTRDkx12cvuW1YLmVuWG4b3n7lhrMS_lG-mO_TfNppbM5842yQUTvrc4MuWJ2kGd0e9V_hYbvB
CitedBy_id crossref_primary_10_3390_ijms222010977
crossref_primary_10_1016_j_febslet_2015_11_033
crossref_primary_10_3390_biology1030668
crossref_primary_10_1242_jcs_123653
crossref_primary_10_1016_j_biocel_2012_11_002
crossref_primary_10_1002_rmv_2240
crossref_primary_10_1016_j_bbamcr_2012_02_014
crossref_primary_10_1016_j_biocel_2016_09_016
crossref_primary_10_1111_acel_12308
crossref_primary_10_1002_jcp_24552
crossref_primary_10_1016_j_biomag_2014_02_006
crossref_primary_10_1186_1742_2094_8_123
crossref_primary_10_1016_j_abb_2017_05_018
crossref_primary_10_1073_pnas_2020152118
crossref_primary_10_3389_fcimb_2022_827717
crossref_primary_10_1016_j_lfs_2012_03_013
crossref_primary_10_1093_jleuko_qiac011
crossref_primary_10_3390_cimb46080523
crossref_primary_10_1016_j_cytogfr_2015_09_001
Cites_doi 10.1128/JVI.02074-06
10.1177/135965350901400109
10.1021/bi902022n
10.1038/nrd2336
10.1371/journal.ppat.0020130
10.1146/annurev.med.53.082901.104024
10.1016/j.antiviral.2009.09.014
10.1002/eji.200737854
10.1016/0891-5849(95)00047-2
10.1016/j.chom.2008.10.004
10.1074/jbc.M704481200
10.1007/s00018-002-8520-9
10.1089/ars.2008.2097
10.1038/sj.emboj.7600900
10.1099/vir.0.016303-0
10.1186/1742-4690-4-52
10.1074/jbc.274.41.28837
10.1038/nri2674
10.1038/cr.2009.137
10.1097/00002030-200317004-00003
10.1186/1742-4690-4-56
10.1016/j.ijrobp.2006.02.040
10.1016/S1054-3589(07)55004-0
10.1016/j.cell.2008.07.032
10.1016/j.virol.2007.02.004
10.1101/gad.1228704
10.1016/S0891-5849(99)00107-0
10.1128/JVI.00599-07
10.1126/science.1152725
10.1016/j.micinf.2005.06.003
10.1128/JVI.75.18.8524-8537.2001
10.1093/nar/28.3.663
10.1128/JVI.66.4.2232-2239.1992
10.1073/pnas.95.23.13519
10.1016/j.virusres.2009.08.005
10.1038/sj.emboj.7601248
10.1006/clim.1999.4831
10.1002/j.1460-2075.1995.tb07030.x
10.1016/j.chom.2008.04.001
10.1016/S1074-7613(00)80326-X
10.1002/j.1460-2075.1995.tb07141.x
10.1016/j.freeradbiomed.2009.04.028
10.1002/j.1460-2075.1993.tb06029.x
10.1074/jbc.M200007200
ContentType Journal Article
Copyright 2010 Elsevier Inc.
Copyright © 2010 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2010 Elsevier Inc.
– notice: Copyright © 2010 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7U9
H94
7S9
L.6
7X8
DOI 10.1016/j.abb.2010.10.018
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList AGRICOLA
AIDS and Cancer Research Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1096-0384
EndPage 272
ExternalDocumentID 21029719
10_1016_j_abb_2010_10_018
S0003986110004534
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-DZ
-~X
.~1
0R~
1B1
1RT
1~.
1~5
23M
4.4
457
4G.
5GY
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABFRF
ABGSF
ABJNI
ABMAC
ABPPZ
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACNCT
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
DM4
DOVZS
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HLW
HZ~
IH2
IHE
J1W
K-O
KOM
L7B
LG5
LX2
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RNS
ROL
RPZ
SDF
SDG
SDP
SES
SPCBC
SSU
SSZ
T5K
TWZ
WH7
~02
~G-
.55
.GJ
.HR
3O-
53G
AAHBH
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABEFU
ABFNM
ABWVN
ACRPL
ACVFH
ADCNI
ADFGL
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGHFR
AGQPQ
AGRDE
AGRNS
AHHHB
AI.
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CAG
CITATION
COF
FEDTE
FGOYB
G-2
HVGLF
MVM
NEJ
OHT
R2-
SBG
SEW
SSH
UQL
VH1
WUQ
X7M
XOL
XPP
YYP
ZGI
ZMT
ZXP
~KM
CGR
CUY
CVF
ECM
EIF
NPM
7U9
EFKBS
H94
7S9
L.6
7X8
ID FETCH-LOGICAL-c418t-cd308d0d18117da2619415af18f277aec14f4e14f64ffb56b239ddd1b79b26503
IEDL.DBID AIKHN
ISSN 0003-9861
1096-0384
IngestDate Fri Sep 05 06:34:17 EDT 2025
Thu Sep 04 22:59:50 EDT 2025
Fri Sep 05 07:53:36 EDT 2025
Thu Apr 03 07:08:48 EDT 2025
Tue Jul 01 03:47:57 EDT 2025
Thu Apr 24 23:11:05 EDT 2025
Fri Feb 23 02:17:47 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords HIV-1
LTR transactivation
Akt
Tat
Nox2
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2010 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c418t-cd308d0d18117da2619415af18f277aec14f4e14f64ffb56b239ddd1b79b26503
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 21029719
PQID 1020855365
PQPubID 23462
PageCount 7
ParticipantIDs proquest_miscellaneous_835116752
proquest_miscellaneous_1720437415
proquest_miscellaneous_1020855365
pubmed_primary_21029719
crossref_citationtrail_10_1016_j_abb_2010_10_018
crossref_primary_10_1016_j_abb_2010_10_018
elsevier_sciencedirect_doi_10_1016_j_abb_2010_10_018
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-01-15
PublicationDateYYYYMMDD 2011-01-15
PublicationDate_xml – month: 01
  year: 2011
  text: 2011-01-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Archives of biochemistry and biophysics
PublicationTitleAlternate Arch Biochem Biophys
PublicationYear 2011
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Wu, Ma, Myers, Terada (b0200) 2007; 282
Annibaldi, Sajeva, Muscolini, Ciccosanti, Corazzari, Piacentini, Tuosto (b0015) 2008; 38
McMichael, Borrow, Tomaras, Goonetilleke, Haynes (b0110) 2010; 10
Hayden, Ghosh (b0060) 2004; 18
Kim, Bourgeois, Pearson, Tyagi, West, Wong, Wu, Chiang, Karn (b0075) 2006; 25
Vignais (b0160) 2002; 59
McKinnon, Mellors, Swindells (b0105) 2009; 14
Wan, Lenardo (b0165) 2010; 20
Williams, Kwon, Chen, Greene (b0190) 2007; 81
Yan, Banerjee (b0230) 2010; 49
Brass, Dykxhoorn, Benita, Yan, Engelman, Xavier, Lieberman, Elledge (b0025) 2008; 319
Marzio, Tyagi, Gutierrez, Giacca (b0100) 1998; 95
Zhou, Xu, Huang, Gates, Zhang, Stec, Ferrer, Strulovici, Hazuda, Espeseth (b0220) 2008; 4
Pereira, Bentley, Peeters, Churchill, Deacon (b0120) 2000; 28
Ranjbar, Tsytsykova, Lee, Rajsbaum, Falvo, Lieberman, Shankar, Goldfeld (b0130) 2006; 2
Kinoshita, Su, Amano, Timmerman, Kaneshima, Nolan (b0085) 1997; 6
Strebel (b0145) 2003; 17
Coiras, Lopez-Huertas, Rullas, Mittelbrunn, Alcami (b0040) 2007; 4
Williams, Chen, Kwon, Ruiz-Jarabo, Verdin, Greene (b0185) 2006; 25
Sgarbanti, Remoli, Marsili, Ridolfi, Borsetti, Perrotti, Orsatti, Ilari, Sernicola, Stellacci, Ensoli, Battistini (b0140) 2008; 82
Konig, Zhou, Elleder, Diamond, Bonamy, Irelan, Chiang, Tu, De Jesua, Seidel, Opaluch, Caldwell, Weitzman, Kuhen, Bandyopadhyay, Ideker, Orth, Miraglia, Bushman, Young, Chanda1 (b0090) 2008; 135
Agrawal, Louboutin, Strayer (b0005) 2007; 363
Hetzer, Dormeyer, Schnolzer, Ott (b0065) 2005; 7
Alcami, Lain de Lera, Folgueira, Pedraza, Jacque, Bachelerie, Noriega, Hay, Harrich, Gaynor (b0010) 1995; 14
Zhang, Li, Zhou, Wu, Zhou (b0210) 2009; 47
Romani, Engelbrecht, Glashoff (b0135) 2010; 91
West, Lowe, Karn (b0175) 2001; 75
Blankson, Persaud, Siliciano (b0225) 2002; 53
Chen-Park, Huang, Noro, Thanos, Ghosh (b0030) 2002; 277
Cihlar, Ray (b0035) 2010; 85
Pace, Leaf (b0115) 1995; 19
Wang, Joseph (b0170) 1999; 27
Kimpton, Emerman (b0080) 1992; 66
Zhang, Wu (b0215) 2009; 146
Cron, Bartz, Clausell, Bort, Klebanoff, Lewis (b0045) 2000; 94
Sun, Huang, Xu, Wang, Bai, Sui, Zhou (b0150) 2006; 65
Lama, Planelles (b0095) 2007; 4
Turchan-Cholewo, Dimayuga, Gupta, Gorospe, Keller, Bruce-Keller (b0155) 2009; 11
Perkins, Edwards, Duckett, Agranoff, Schmid, Nabel (b0125) 1999; 12
Gatignol (b0055) 2007; 55
Westendorp, Shatrov, Schulze-Osthoff, Frank, Kraft, Los, Krammer, Droge, Lehmann (b0180) 1995; 14
Winkler (b0195) 2008; 3
Jeang, Xiao, Rich (b0070) 1999; 274
Flexner (b0050) 2007; 6
Kim (10.1016/j.abb.2010.10.018_b0075) 2006; 25
Pace (10.1016/j.abb.2010.10.018_b0115) 1995; 19
Williams (10.1016/j.abb.2010.10.018_b0190) 2007; 81
Zhang (10.1016/j.abb.2010.10.018_b0210) 2009; 47
Sun (10.1016/j.abb.2010.10.018_b0150) 2006; 65
Strebel (10.1016/j.abb.2010.10.018_b0145) 2003; 17
Agrawal (10.1016/j.abb.2010.10.018_b0005) 2007; 363
Williams (10.1016/j.abb.2010.10.018_b0185) 2006; 25
Chen-Park (10.1016/j.abb.2010.10.018_b0030) 2002; 277
Kinoshita (10.1016/j.abb.2010.10.018_b0085) 1997; 6
Wu (10.1016/j.abb.2010.10.018_b0200) 2007; 282
Vignais (10.1016/j.abb.2010.10.018_b0160) 2002; 59
Yan (10.1016/j.abb.2010.10.018_b0230) 2010; 49
McKinnon (10.1016/j.abb.2010.10.018_b0105) 2009; 14
Lama (10.1016/j.abb.2010.10.018_b0095) 2007; 4
Pereira (10.1016/j.abb.2010.10.018_b0120) 2000; 28
Wan (10.1016/j.abb.2010.10.018_b0165) 2010; 20
Brass (10.1016/j.abb.2010.10.018_b0025) 2008; 319
Cihlar (10.1016/j.abb.2010.10.018_b0035) 2010; 85
Turchan-Cholewo (10.1016/j.abb.2010.10.018_b0155) 2009; 11
Marzio (10.1016/j.abb.2010.10.018_b0100) 1998; 95
Alcami (10.1016/j.abb.2010.10.018_b0010) 1995; 14
Winkler (10.1016/j.abb.2010.10.018_b0195) 2008; 3
Gatignol (10.1016/j.abb.2010.10.018_b0055) 2007; 55
Ranjbar (10.1016/j.abb.2010.10.018_b0130) 2006; 2
Annibaldi (10.1016/j.abb.2010.10.018_b0015) 2008; 38
Hetzer (10.1016/j.abb.2010.10.018_b0065) 2005; 7
Cron (10.1016/j.abb.2010.10.018_b0045) 2000; 94
Wang (10.1016/j.abb.2010.10.018_b0170) 1999; 27
Hayden (10.1016/j.abb.2010.10.018_b0060) 2004; 18
Coiras (10.1016/j.abb.2010.10.018_b0040) 2007; 4
Jeang (10.1016/j.abb.2010.10.018_b0070) 1999; 274
West (10.1016/j.abb.2010.10.018_b0175) 2001; 75
Westendorp (10.1016/j.abb.2010.10.018_b0180) 1995; 14
Romani (10.1016/j.abb.2010.10.018_b0135) 2010; 91
Zhang (10.1016/j.abb.2010.10.018_b0215) 2009; 146
Kimpton (10.1016/j.abb.2010.10.018_b0080) 1992; 66
Flexner (10.1016/j.abb.2010.10.018_b0050) 2007; 6
Blankson (10.1016/j.abb.2010.10.018_b0225) 2002; 53
Sgarbanti (10.1016/j.abb.2010.10.018_b0140) 2008; 82
Perkins (10.1016/j.abb.2010.10.018_b0125) 1999; 12
McMichael (10.1016/j.abb.2010.10.018_b0110) 2010; 10
Konig (10.1016/j.abb.2010.10.018_b0090) 2008; 135
Zhou (10.1016/j.abb.2010.10.018_b0220) 2008; 4
References_xml – volume: 6
  start-page: 235
  year: 1997
  end-page: 244
  ident: b0085
  publication-title: Immunity
– volume: 277
  start-page: 24701
  year: 2002
  end-page: 24708
  ident: b0030
  publication-title: J. Biol. Chem.
– volume: 2
  start-page: e130
  year: 2006
  ident: b0130
  article-title: NFAT 5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site
  publication-title: PLoS Pathog.
– volume: 65
  start-page: 842
  year: 2006
  end-page: 850
  ident: b0150
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
– volume: 49
  start-page: 1059
  year: 2010
  end-page: 1066
  ident: b0230
  publication-title: Biochemistry
– volume: 85
  start-page: 39
  year: 2010
  end-page: 58
  ident: b0035
  publication-title: Antiviral. Res.
– volume: 82
  start-page: 3632
  year: 2008
  end-page: 3641
  ident: b0140
  publication-title: J. Virol.
– volume: 55
  start-page: 137
  year: 2007
  end-page: 159
  ident: b0055
  publication-title: Adv. Pharmacol.
– volume: 20
  start-page: 24
  year: 2010
  end-page: 33
  ident: b0165
  publication-title: Cell Res.
– volume: 25
  start-page: 139
  year: 2006
  end-page: 149
  ident: b0185
  publication-title: EMBO J.
– volume: 319
  start-page: 921
  year: 2008
  end-page: 926
  ident: b0025
  publication-title: Science
– volume: 274
  start-page: 28837
  year: 1999
  end-page: 28840
  ident: b0070
  publication-title: Tat. J. Biol. Chem.
– volume: 95
  start-page: 13519
  year: 1998
  end-page: 13524
  ident: b0100
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 17
  start-page: S25
  year: 2003
  end-page: 34
  ident: b0145
  publication-title: AIDS
– volume: 27
  start-page: 612
  year: 1999
  end-page: 616
  ident: b0170
  publication-title: Free Radic. Biol. Med.
– volume: 3
  start-page: 203
  year: 2008
  end-page: 205
  ident: b0195
  publication-title: Cell Host Microbe.
– volume: 14
  start-page: 1
  year: 2009
  end-page: 12
  ident: b0105
  publication-title: Antivir. Ther.
– volume: 25
  start-page: 3596
  year: 2006
  end-page: 3604
  ident: b0075
  publication-title: EMBO J.
– volume: 4
  start-page: 52
  year: 2007
  ident: b0095
  publication-title: Retrovirology
– volume: 53
  start-page: 557
  year: 2002
  end-page: 593
  ident: b0225
  publication-title: Annu. Rev. Med.
– volume: 12
  start-page: 3551
  year: 1999
  end-page: 3558
  ident: b0125
  publication-title: EMBO J.
– volume: 363
  start-page: 462
  year: 2007
  end-page: 472
  ident: b0005
  publication-title: Virology
– volume: 81
  start-page: 6043
  year: 2007
  end-page: 6056
  ident: b0190
  publication-title: J. Virol.
– volume: 18
  start-page: 2195
  year: 2004
  end-page: 2224
  ident: b0060
  publication-title: Genes Dev.
– volume: 6
  start-page: 959
  year: 2007
  end-page: 966
  ident: b0050
  publication-title: Nat. Rev. Drug Discov.
– volume: 94
  start-page: 179
  year: 2000
  end-page: 191
  ident: b0045
  publication-title: Clin. Immunol.
– volume: 47
  start-page: 261
  year: 2009
  end-page: 268
  ident: b0210
  publication-title: Free Radical. Biol. Med.
– volume: 14
  start-page: 1552
  year: 1995
  end-page: 1560
  ident: b0010
  publication-title: EMBO J.
– volume: 28
  start-page: 663
  year: 2000
  end-page: 668
  ident: b0120
  publication-title: Nucl. Acids Res.
– volume: 91
  start-page: 1
  year: 2010
  end-page: 12
  ident: b0135
  publication-title: J. Gen. Virol.
– volume: 38
  start-page: 1446
  year: 2008
  end-page: 1451
  ident: b0015
  publication-title: Eur. J. Immunol.
– volume: 59
  start-page: 1428
  year: 2002
  end-page: 1459
  ident: b0160
  publication-title: Cell Mol. Life Sci.
– volume: 7
  start-page: 1364
  year: 2005
  end-page: 1369
  ident: b0065
  publication-title: Microbes Infect.
– volume: 146
  start-page: 51
  year: 2009
  end-page: 57
  ident: b0215
  publication-title: Virus Res.
– volume: 135
  start-page: 49
  year: 2008
  end-page: 60
  ident: b0090
  publication-title: Cell
– volume: 4
  start-page: 56
  year: 2007
  ident: b0040
  publication-title: Retrovirology
– volume: 14
  start-page: 546
  year: 1995
  end-page: 554
  ident: b0180
  publication-title: EMBO J.
– volume: 66
  start-page: 2232
  year: 1992
  end-page: 2239
  ident: b0080
  publication-title: J. Virol.
– volume: 11
  start-page: 193
  year: 2009
  end-page: 204
  ident: b0155
  publication-title: Antioxid. Redox Signal.
– volume: 75
  start-page: 8524
  year: 2001
  end-page: 8537
  ident: b0175
  publication-title: J. Virol.
– volume: 10
  start-page: 11
  year: 2010
  end-page: 23
  ident: b0110
  publication-title: Nat. Rev. Immunol.
– volume: 19
  start-page: 523
  year: 1995
  end-page: 528
  ident: b0115
  publication-title: Free Radic. Biol. Med.
– volume: 282
  start-page: 37412
  year: 2007
  end-page: 37419
  ident: b0200
  publication-title: J. Biol. Chem.
– volume: 4
  start-page: 495
  year: 2008
  end-page: 504
  ident: b0220
  publication-title: Cell Host Microbe.
– volume: 81
  start-page: 6043
  year: 2007
  ident: 10.1016/j.abb.2010.10.018_b0190
  publication-title: J. Virol.
  doi: 10.1128/JVI.02074-06
– volume: 14
  start-page: 1
  year: 2009
  ident: 10.1016/j.abb.2010.10.018_b0105
  publication-title: Antivir. Ther.
  doi: 10.1177/135965350901400109
– volume: 49
  start-page: 1059
  year: 2010
  ident: 10.1016/j.abb.2010.10.018_b0230
  publication-title: Biochemistry
  doi: 10.1021/bi902022n
– volume: 6
  start-page: 959
  year: 2007
  ident: 10.1016/j.abb.2010.10.018_b0050
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2336
– volume: 2
  start-page: e130
  year: 2006
  ident: 10.1016/j.abb.2010.10.018_b0130
  article-title: NFAT 5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.0020130
– volume: 53
  start-page: 557
  year: 2002
  ident: 10.1016/j.abb.2010.10.018_b0225
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev.med.53.082901.104024
– volume: 85
  start-page: 39
  year: 2010
  ident: 10.1016/j.abb.2010.10.018_b0035
  publication-title: Antiviral. Res.
  doi: 10.1016/j.antiviral.2009.09.014
– volume: 38
  start-page: 1446
  year: 2008
  ident: 10.1016/j.abb.2010.10.018_b0015
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200737854
– volume: 19
  start-page: 523
  year: 1995
  ident: 10.1016/j.abb.2010.10.018_b0115
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/0891-5849(95)00047-2
– volume: 4
  start-page: 495
  year: 2008
  ident: 10.1016/j.abb.2010.10.018_b0220
  publication-title: Cell Host Microbe.
  doi: 10.1016/j.chom.2008.10.004
– volume: 282
  start-page: 37412
  year: 2007
  ident: 10.1016/j.abb.2010.10.018_b0200
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M704481200
– volume: 59
  start-page: 1428
  year: 2002
  ident: 10.1016/j.abb.2010.10.018_b0160
  publication-title: Cell Mol. Life Sci.
  doi: 10.1007/s00018-002-8520-9
– volume: 11
  start-page: 193
  year: 2009
  ident: 10.1016/j.abb.2010.10.018_b0155
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2008.2097
– volume: 25
  start-page: 139
  year: 2006
  ident: 10.1016/j.abb.2010.10.018_b0185
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7600900
– volume: 91
  start-page: 1
  year: 2010
  ident: 10.1016/j.abb.2010.10.018_b0135
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.016303-0
– volume: 4
  start-page: 52
  year: 2007
  ident: 10.1016/j.abb.2010.10.018_b0095
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-4-52
– volume: 274
  start-page: 28837
  year: 1999
  ident: 10.1016/j.abb.2010.10.018_b0070
  publication-title: Tat. J. Biol. Chem.
  doi: 10.1074/jbc.274.41.28837
– volume: 10
  start-page: 11
  year: 2010
  ident: 10.1016/j.abb.2010.10.018_b0110
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2674
– volume: 20
  start-page: 24
  year: 2010
  ident: 10.1016/j.abb.2010.10.018_b0165
  publication-title: Cell Res.
  doi: 10.1038/cr.2009.137
– volume: 17
  start-page: S25
  year: 2003
  ident: 10.1016/j.abb.2010.10.018_b0145
  publication-title: AIDS
  doi: 10.1097/00002030-200317004-00003
– volume: 4
  start-page: 56
  year: 2007
  ident: 10.1016/j.abb.2010.10.018_b0040
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-4-56
– volume: 65
  start-page: 842
  year: 2006
  ident: 10.1016/j.abb.2010.10.018_b0150
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2006.02.040
– volume: 55
  start-page: 137
  year: 2007
  ident: 10.1016/j.abb.2010.10.018_b0055
  publication-title: Adv. Pharmacol.
  doi: 10.1016/S1054-3589(07)55004-0
– volume: 135
  start-page: 49
  year: 2008
  ident: 10.1016/j.abb.2010.10.018_b0090
  publication-title: Cell
  doi: 10.1016/j.cell.2008.07.032
– volume: 363
  start-page: 462
  year: 2007
  ident: 10.1016/j.abb.2010.10.018_b0005
  publication-title: Virology
  doi: 10.1016/j.virol.2007.02.004
– volume: 18
  start-page: 2195
  year: 2004
  ident: 10.1016/j.abb.2010.10.018_b0060
  publication-title: Genes Dev.
  doi: 10.1101/gad.1228704
– volume: 27
  start-page: 612
  year: 1999
  ident: 10.1016/j.abb.2010.10.018_b0170
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/S0891-5849(99)00107-0
– volume: 82
  start-page: 3632
  year: 2008
  ident: 10.1016/j.abb.2010.10.018_b0140
  publication-title: J. Virol.
  doi: 10.1128/JVI.00599-07
– volume: 319
  start-page: 921
  year: 2008
  ident: 10.1016/j.abb.2010.10.018_b0025
  publication-title: Science
  doi: 10.1126/science.1152725
– volume: 7
  start-page: 1364
  year: 2005
  ident: 10.1016/j.abb.2010.10.018_b0065
  publication-title: Microbes Infect.
  doi: 10.1016/j.micinf.2005.06.003
– volume: 75
  start-page: 8524
  year: 2001
  ident: 10.1016/j.abb.2010.10.018_b0175
  publication-title: J. Virol.
  doi: 10.1128/JVI.75.18.8524-8537.2001
– volume: 28
  start-page: 663
  year: 2000
  ident: 10.1016/j.abb.2010.10.018_b0120
  publication-title: Nucl. Acids Res.
  doi: 10.1093/nar/28.3.663
– volume: 66
  start-page: 2232
  year: 1992
  ident: 10.1016/j.abb.2010.10.018_b0080
  publication-title: J. Virol.
  doi: 10.1128/JVI.66.4.2232-2239.1992
– volume: 95
  start-page: 13519
  year: 1998
  ident: 10.1016/j.abb.2010.10.018_b0100
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.95.23.13519
– volume: 146
  start-page: 51
  year: 2009
  ident: 10.1016/j.abb.2010.10.018_b0215
  publication-title: Virus Res.
  doi: 10.1016/j.virusres.2009.08.005
– volume: 25
  start-page: 3596
  year: 2006
  ident: 10.1016/j.abb.2010.10.018_b0075
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7601248
– volume: 94
  start-page: 179
  year: 2000
  ident: 10.1016/j.abb.2010.10.018_b0045
  publication-title: Clin. Immunol.
  doi: 10.1006/clim.1999.4831
– volume: 14
  start-page: 546
  year: 1995
  ident: 10.1016/j.abb.2010.10.018_b0180
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1995.tb07030.x
– volume: 3
  start-page: 203
  year: 2008
  ident: 10.1016/j.abb.2010.10.018_b0195
  publication-title: Cell Host Microbe.
  doi: 10.1016/j.chom.2008.04.001
– volume: 6
  start-page: 235
  year: 1997
  ident: 10.1016/j.abb.2010.10.018_b0085
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80326-X
– volume: 14
  start-page: 1552
  year: 1995
  ident: 10.1016/j.abb.2010.10.018_b0010
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1995.tb07141.x
– volume: 47
  start-page: 261
  year: 2009
  ident: 10.1016/j.abb.2010.10.018_b0210
  publication-title: Free Radical. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2009.04.028
– volume: 12
  start-page: 3551
  year: 1999
  ident: 10.1016/j.abb.2010.10.018_b0125
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1993.tb06029.x
– volume: 277
  start-page: 24701
  year: 2002
  ident: 10.1016/j.abb.2010.10.018_b0030
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M200007200
SSID ssj0011462
Score 2.0951552
Snippet ► Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is involved in Tat-induced NADPH oxidase stimulation. ► NF-κB nuclear translocation in Tat-treated...
Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR)...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 266
SubjectTerms 1-Phosphatidylinositol 3-kinase
adenine
Akt
AKT protein
CYBB protein
Data processing
enzyme inhibition
enzyme inhibitors
Enzymes
HeLa Cells
HIV-1
HIV-1 - genetics
HIV-1 - metabolism
Human immunodeficiency virus 1
Humans
I-kappa B Proteins - metabolism
IKK protein
Long terminal repeat
LTR transactivation
Membrane Glycoproteins - metabolism
NAD(P)H oxidase
NAD(P)H oxidase (H2O2-forming)
NADP (coenzyme)
NADPH Oxidase 2
NADPH Oxidases - metabolism
NF- Kappa B protein
NF-kappa B - metabolism
nicotinamide
Nox2
NOX4 protein
Oxidative Stress
Phosphatidylinositol 3-Kinase - metabolism
Phosphorylation
Proto-Oncogene Proteins c-akt - metabolism
Reactive oxygen species
Reactive Oxygen Species - metabolism
regulatory proteins
Signal Transduction
siRNA
small interfering RNA
Tat
tat Gene Products, Human Immunodeficiency Virus - metabolism
Tat protein
terminal repeat sequences
Terminal Repeat Sequences - genetics
Transcription Factor RelA - metabolism
Transcriptional Activation
Wortmannin
Title Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation
URI https://dx.doi.org/10.1016/j.abb.2010.10.018
https://www.ncbi.nlm.nih.gov/pubmed/21029719
https://www.proquest.com/docview/1020855365
https://www.proquest.com/docview/1720437415
https://www.proquest.com/docview/835116752
Volume 505
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tnRC8INj4KB-TkRACJNM4sRP3sauoOj76gDq0t8iOHanQpdWWAXvhD-OP4G_iLokrIbE-8BJZyVlyfPZ9-O78A3heFjZKjdFcljLh0hrFbaIdz5AjDjVs5gwVOH-cpdMT-e5Une7AONTCUFplJ_tbmd5I6-7NoJvNwXqxoBrfKBnqlO48Q7skkbuwF6O21z3YGx2_n842wQQUBnEAzqMOIbjZpHkZa9sEL8rxIuiPf6un68zPRg1N7sDtzn5ko3aId2HHV_twMKrQdz67Yi9Yk9HZHJXvw42j0Lo5DrhuB3A2-loPZqsf8WA24b9_HTFK4TBUlc4Invi7uWKLC7aoUG598w4bbG5qjq47LgLHpsefuWDLFVJ3eTRLdu7XKNHZyw_zT69YHQDI27Pee3AyeTsfT3kHusALKXTNC5dE2kVOUAWqM-RgoY43pdBlnGXGFwK56vGRyrK0KrU45845YbOhjdHcS-5Dr1pV_iEwp5ym_Z-UUslCFaZE3VeqWFofZ0bbPkRhrvOiu5GcgDGWeUg9-5Ije3JiD71C9vTh9abLur2OYxuxDAzM_1pTOaqLbd2eBWbnyBoKoJjKry4v8DshmqokVVtoCPUnITutD-waGk3RW_TU4j48aBfT5mfIAx9mYvjo_8b-GG61h96CC_UEevX5pX-KVlNtD2H3zU9x2O2NP0wWE80
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFD4andC4QbDBKAwwEkKAZDWJnb_LrqJKWZcL1KHdRXacSIUurbZsY6-2h9gz7ZwkroTEesFNZCW25Pizz499jj-Aj2WunUCpiMtSCi618rkWkeEhImJQw4ZGUYLzcRokJ_L7qX-6BSObC0NhlZ3sb2V6I627N4NuNAer-ZxyfB0RRwHdeYZ2iZCPYFsSqXUPtoeToyRdHyagMPAscR41sIebTZiX0roN8KIYL6L--Ld6esj8bNTQ-Bk87exHNmy7-By2imoX9oYV-s5nN-wTayI6m63yXXh8aEs7I8vrtgdnw9_1IF3-8QbpmN_dHjIK4VCUlc6Invha3bD5BZtXKLeuCoMFNlM1R9cdJ4FhyeQnd9liibW7OJoFOy9WKNHZ5-nsxxdWWwLydq_3BZyMv81GCe9IF3gu3ajmuRFOZBzjUgaqUeRgoY5XpRuVXhiqIncR1QIfgSxL7QfaE7ExxtVhrD0098RL6FXLqngFzPgmovUvSsQl93NVou4rfU_qwgtVpPvg2LHO8u5GciLGWGQ29OxXhvBkBA-9Qnj68HXdZNVex7GpsrQAZn_NqQzVxaZmHyzYGUJDByiqKpaXF_idGE19Efgb6hDrjyA7rQ_sgToRnd6ip-b1Yb-dTOufIQ88Dt349f_1_T3sJLPjaTadpEdv4Em7Ae5y1z-AXn1-WbxFC6rW77oVcg_I9BWz
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Akt%2FNox2%2FNF-%CE%BAB+signaling+pathway+is+involved+in+Tat-induced+HIV-1+long+terminal+repeat+%28LTR%29+transactivation&rft.jtitle=Archives+of+biochemistry+and+biophysics&rft.au=Zhang%2C+Hong-Sheng&rft.au=Sang%2C+Wei-Wei&rft.au=Ruan%2C+Zheng&rft.au=Wang%2C+Yu-Ou&rft.date=2011-01-15&rft.issn=0003-9861&rft.volume=505&rft.issue=2+p.266-272&rft.spage=266&rft.epage=272&rft_id=info:doi/10.1016%2Fj.abb.2010.10.018&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9861&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9861&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9861&client=summon